Hansa Biopharma Hosts Virtual Event with Distinguished Transplant Surgeons
Hansa Biopharma AB announced a virtual event featuring Professor Robert Montgomery and Professor Matthew Cooper to discuss clinical practice and imlifidase Phase 3 results.
The event will take place on November 12, 2025, at 9:00 AM EST / 15:00 PM CET, focusing on the medical journey of highly sensitized patients awaiting a kidney transplant.
The topline results from the US Phase 3 ConfIdeS study will be shared, providing insights into the clinical relevance of imlifidase.
For more information, contact +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT.
Author's summary: Hansa Biopharma hosts virtual event on imlifidase Phase 3 results.
More News
- Elite sheep dogs to go head-to-head at Ashburton A&P Show
- Commentary | Living with the Long Emergency by Tim Stevenson: Trump’s galloping fear and pervasive insecurity
- 3 Witch Folklore 'Potions' That Actually Have Medical Significance Today
- What’s Behind The BigLaw Litigation Hiring Surge? What’s Behind The BigLaw Litigation Hiring Surge? -
- Other voices: Most Americans don’t think either Democrats or Republicans care about them
- Galloping Islamization in Britain and America - EJP
- Other voices: The great Trump-Putin breakup and why it matters